These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 19819686)

  • 1. Advances in stem cell research for Amyotrophic Lateral Sclerosis.
    Papadeas ST; Maragakis NJ
    Curr Opin Biotechnol; 2009 Oct; 20(5):545-51. PubMed ID: 19819686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of amyotrophic lateral sclerosis patients by autologous bone marrow-derived hematopoietic stem cell transplantation: a 1-year follow-up.
    Deda H; Inci MC; Kürekçi AE; Sav A; Kayihan K; Ozgün E; Ustünsoy GE; Kocabay S
    Cytotherapy; 2009; 11(1):18-25. PubMed ID: 19012065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stem therapy for ALS: hope and reality.
    Silani V; Leigh N
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Apr; 4(1):8-10. PubMed ID: 12745611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toward the treatments with neural stem cells: experiences from amyotrophic lateral sclerosis.
    Mitrecić D; Gajović S; Pochet R
    Anat Rec (Hoboken); 2009 Dec; 292(12):1962-7. PubMed ID: 19943351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The causes and mechanism of selective motor neuron death in amyotrophic lateral sclerosis].
    Van den Bosch L
    Verh K Acad Geneeskd Belg; 2006; 68(4):249-69. PubMed ID: 17214440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted stem cell transplantation strategies in ALS.
    Lepore AC; Maragakis NJ
    Neurochem Int; 2007 Jun; 50(7-8):966-75. PubMed ID: 17055612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
    Liu Y; Deng W
    Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stem cell treatment in Amyotrophic Lateral Sclerosis.
    Mazzini L; Mareschi K; Ferrero I; Vassallo E; Oliveri G; Nasuelli N; Oggioni GD; Testa L; Fagioli F
    J Neurol Sci; 2008 Feb; 265(1-2):78-83. PubMed ID: 17582439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cellular therapy in amyotrophic lateral sclerosis].
    Matías-Guiu J; Barcia JA; García-Verdugo JM; Galán L; Vela A; García-Ramos R
    Neurologia; 2008 May; 23(4):226-37. PubMed ID: 18307053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular and molecular approaches to motor neuron therapy in amyotrophic lateral sclerosis and spinal muscular atrophy.
    O'Connor DM; Boulis NM
    Neurosci Lett; 2012 Oct; 527(2):78-84. PubMed ID: 22579818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stem cell therapy in amyotrophic lateral sclerosis.
    Meamar R; Nasr-Esfahani MH; Mousavi SA; Basiri K
    J Clin Neurosci; 2013 Dec; 20(12):1659-63. PubMed ID: 24148693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neural stem cells LewisX+ CXCR4+ modify disease progression in an amyotrophic lateral sclerosis model.
    Corti S; Locatelli F; Papadimitriou D; Del Bo R; Nizzardo M; Nardini M; Donadoni C; Salani S; Fortunato F; Strazzer S; Bresolin N; Comi GP
    Brain; 2007 May; 130(Pt 5):1289-305. PubMed ID: 17439986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stem cells and the ALS neurologist.
    Maragakis NJ
    Amyotroph Lateral Scler; 2010 Oct; 11(5):417-23. PubMed ID: 20509745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is it too soon for mesenchymal stem cell trials in people with ALS?
    Badayan I; Cudkowicz ME
    Amyotroph Lateral Scler; 2008 Dec; 9(6):321-2. PubMed ID: 18819027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic targets for amyotrophic lateral sclerosis: current treatments and prospects for more effective therapies.
    Bruijn LI; Cudkowicz M
    Expert Rev Neurother; 2006 Mar; 6(3):417-28. PubMed ID: 16533145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nerve cells made from elderly patient's skin cells.
    Baker M
    Nature; 2008 Aug; 454(7205):675. PubMed ID: 18685662
    [No Abstract]   [Full Text] [Related]  

  • 17. [Classical and atypical clinical features in amyotrophic lateral sclerosis].
    Pradat PF; Bruneteau G
    Rev Neurol (Paris); 2006 Jun; 162 Spec No 2():4S17-4S24. PubMed ID: 17128085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hematopoietic stem cell transplantation in patients with sporadic amyotrophic lateral sclerosis.
    Appel SH; Engelhardt JI; Henkel JS; Siklos L; Beers DR; Yen AA; Simpson EP; Luo Y; Carrum G; Heslop HE; Brenner MK; Popat U
    Neurology; 2008 Oct; 71(17):1326-34. PubMed ID: 18936424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Axon guidance proteins: novel therapeutic targets for ALS?
    Schmidt ER; Pasterkamp RJ; van den Berg LH
    Prog Neurobiol; 2009 Aug; 88(4):286-301. PubMed ID: 19523502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stem cells for amyotrophic lateral sclerosis modeling and therapy: myth or fact?
    Coatti GC; Beccari MS; Olávio TR; Mitne-Neto M; Okamoto OK; Zatz M
    Cytometry A; 2015 Mar; 87(3):197-211. PubMed ID: 25645594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.